Wire Stories
-
597Kioxia Announces 2nd Generation 24G SAS SSD, With a Focus on Performance and Security
NIST FIPS 140-2-Certified PM7 Series Leverages Latest BiCS FLASH� Technology and Currently Under Test for FIPS 140-3 Certification TOKYO–(BUSINESS WIRE)–#24GSAS—Kioxia Corporation today...
-
751
Wemade Announces the Arrival of �Black Flame Arch Demon Nerkan�
MIR4 unveils a new world boss. SEOUL, South Korea–(BUSINESS WIRE)–#112040KOSDAQ–Wemade, developer of the globally acclaimed MMORPG, MIR4, announces the arrival of a...
-
485
Oasis Announces �Women�s Director Training Scholarship� Initiative for International Women�s Day in Cooperation with BDTI of Japan
Investment firm Oasis to sponsor board director training courses through The Board Director Training Institute of Japan for all qualified women who...
-
535
Fiserv Hires Miriam Park as General Manager for Korea
Fiserv strengthens its payment services business in Asia Pacific with appointment of cards veteran Miriam Park as General Manager for Korea BROOKFIELD,...
-
534
New Avetta One� Platform Provides Pegasus Customers with a Unified View of Supply Chain Risk for Companies & Suppliers
Global reach of Pegasus continues to expand with Avetta One, offering a single-source solution for managing health & safety, ESG & contractor/supplier...
-
529
Investigation Report on China’s Omalizumab Markets, 2016-2020 & 2021-2025: Developed by Novartis Europharm – The Only Approved antibody designed to Target and Block Immunoglobulin E (IgE) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Omalizumab Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Omalizumab, developed by Novartis Europharm, is...
-
506
China Abiraterone Markets Investigation Report, 2016-2020 & 2021-2025: A CYP17 Inhibitor, Which is Mainly Clinically Used to Treat Prostate Cancer Patients – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Abiraterone Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Abiraterone is a CYP17 inhibitor, which...
-
492
China Express Delivery Industry Report 2021: Analysis 2016-2020, Competition Status 2016-2020, Cost & Prices 2016-2020, & Forecasts 2021-2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Express Delivery Industry 2021-2025” report has been added to ResearchAndMarkets.com’s offering. In 2020, China’s online retail...
-
542
Investigation Report on China’s Daratumumab Markets, 2016-2020 & 2021-2025: Developed by Johnson & Johnson – A Monoclonal Antibody Available for the Treatment of Myeloma – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Daratumumab Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Daratumumab, developed by Johnson & Johnson,...
-
530
Investigation Report on China’s Pertuzumab Markets, 2016-2020 & 2021-2025: The First Monoclonal Antibody Called “HER Dimerization inhibitor”, Mainly Used to Treat HER2-Positive Breast Cancer – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Pertuzumab Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Pertuzumab is the first monoclonal antibody...
